Recursion Pharmaceuticals (RXRX) FCF Margin Growth (1y) (2021 - 2026)
Recursion Pharmaceuticals (RXRX) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 5,389.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1,525.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.71 Bn | 1.05 Bn | -6.02 Mn | -35,041.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35,041.00 |
| Dec 31, 2025 | 241,994.00 |
| Sep 30, 2025 | -201,874.00 |
| Jun 30, 2025 | 18,555.00 |
| Mar 31, 2025 | -11,284.00 |
| Dec 31, 2024 | -195,594.00 |
| Sep 30, 2024 | 54,156.00 |
| Jun 30, 2024 | 3,174.00 |
| Mar 31, 2024 | -18,363.00 |
| Dec 31, 2023 | -3,621.00 |
| Sep 30, 2023 | -50,636.00 |
| Jun 30, 2023 | 40,747.00 |
| Mar 31, 2023 | -197,593.00 |
| Dec 31, 2022 | 201,512.00 |
| Sep 30, 2022 | 238,870.00 |
| Jun 30, 2022 | -42,923.00 |
| Mar 31, 2022 | 332,797.00 |
| Dec 31, 2021 | -293,691.00 |
| Sep 30, 2021 | -56,222.00 |
| Jun 30, 2021 | 802,766.00 |